Auto-Injector Market Size is forecasted to grow during forecast year 2032

 

Auto-Injectors Global Market – Overview

Global Auto-Injectors market size is expected to reach USD 8.80 billion by 2032 and is expected to grow at a CAGR of 14.2% during the forecast period 2023 – 2032. The global market for auto-injectors is growing rapidly. Increasing prevalence and incidences of anaphylaxis and food allergies around the world is majorly responsible for the growth of the global auto-injectors market.  According to the recent Market Study Report “Global Auto-Injectors Market” published by the Market Research Future.

Auto-injectors are spring-loaded syringes, designed to deliver a single dose of a particular life-saving drug. Auto injectors, as the name suggests, are easy to use and are intended for self –administration by patients, or can be administered by untrained personnel. These injectors were initially designed to overcome the hesitation associated with self-administration of the needle-based drug delivery device. Most of the injectors are spring-loaded based.

In an Auto injector the needle tip is covered/ shielded prior to injection, Injection depth can be adjustable with a passive safety mechanism to prevent accidental injection. At the touch of a button, Auto injector automatically inserts the needle and contents of the syringe into the skin without the user having to see the needle. Auto-injectors not only allow the automatic injection of the syringe but also have a visual indication to confirm that the full dose has been delivered, factors as such affirm that Auto injectors are completely safe and reliable for the self-administration of drug delivery and are preferred over the traditional syringe among the needle-based drug delivery devices.

Auto-Injectors Market Regional Analysis

Globally North America is the largest market for auto-injectors.

Europe is the second-largest market for auto-injectors. Asia pacific region is expected to be fastest growing region in auto-injectors market.

Growth of biologics and entry of biosimilar in leading pharma markets such as the U.S. and Europe is expected to be the key driver for growth of the injectable drug delivery market for the forecast period.

Auto-Injectors Global Market - Key Players

While commenting upon this deep diving study report, presented through more than 100 market data tables and figures, widely spread over 85 pages, the MRFR Research Analyst also mentions that Auto injectors normally are made of glass syringes making them fragile and a probable cause of contamination. Currently, the players of the market are striving to create auto injectors syringes with plastic to prevent unnecessary contamination, confirms MRFR Analysis. 

MRFR Analysis identifies following corporations as the key players operating in the global market of auto injectors some of them are:

• UNILIFE CORPORATION,
• Scandinavian Health Ltd,
• Owen Mumford Ltd. (UK),
• kaleo, Inc.,
• Amedra Pharmaceuticals LLC,
• Enbrel and others.

Auto-Injectors Global Market - Segments:

Auto-Injectors Market has been segmented in to 3 key dynamics for an enhanced understanding and convenience of the report.

Segmentation by Product Type          : Comprising - Disposable, Reusable and others

Segmentation by Application             : Comprising - Anaphylaxis, Allergies, Multiple Sclerosis, Rheumatoid Arthritis and others

Segmentation by suppliers                : Comprising - Online Retailers, Pharmacy, Retailers

About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street,5Th Floor, New York,

New York 10013

United States of America

Drug Device Combination Market Share, Insights and Forecast to 2032

Market Analysis

The global drug device combination market share is predicted to grow at a whopping 7.2% CAGR over the assessment period 2023-2032. Drug-device combination products relate a drug with that of a medical device to bridge various regulatory frameworks (device or drug). This can be a single product having several components such as drug-eluting stents, transdermal patches or products that are separately packed yet intended for use exclusively with a definite counterpart. Drug-device combination products offer an array of advantages namely targeted drug delivery, improved patient compliance, controlled drug administration and minimal side effects. Owing to its increased sophistication and different advantages, drug device combination products are widely adopted all across the medical sector.

There are plentiful factors that is boosting the growth of the drug device combination market. These factors as per the Market Research Future (MRFR) report include increasing incidences of urology, prostate cancer, diabetic neuropathy, colorectal cancer, respiratory problems and cardiovascular diseases, growing healthcare expenditure, increasing awareness of market products, growing geriatric population, technological advancements in the drug-device combination product, increase in homebased healthcare market, high market potential, and increase in healthcare expenditure. On the contrary, side effects, existence of low-income countries, soaring price of products, strict government rules for the approval of these devices and errors and post-complications leading to various product recalls are factors that may deter drug device combination market growth.

Key Players

Drug device combination market players profiled in the industry include

Zimmer Holding, Inc,

Wright Medical Group, Inc.,

Stryker Corporation,

St. Jude Medical Inc,

Smith & Nephew Plc,

Covidien Ltd,

Cook Critical Care, Inc.,

C.R. BARD, Inc.,

Boston Scientific Corporation,

Biotronik,

Biometrix Medical,

Biomet Orthopedics, Inc,

AlloSource,

Abbott Laboratories,

3M, and others.

Market Segmentation

MRFR report provides an extensive segmental analysis of the drug device combination market outlook on the basis of product, application and end-users.

Based on product, it is segmented into advanced wound care products, catheter and others. Catheter is again segmented into wound drainage catheter, thermodilution catheters, oximetry catheters, cardiovascular catheters, urological catheters, antimicrobial catheter and others. Advanced wound care products are again segmented into photodynamic therapy, drug eluting stents, antibiotic bone cements, bone graft substitutes and antibiotic wound care. Bone graft substitutes is again segmented into cell-based bone graft substitutes, allograft-based bone graft substitutes, ceramic based bone graft substitute and others.

Based on application, the drug device combination market is segmented into ophthalmic treatment, wound care, antimicrobial applications, bone treatment, peripheral arterial disease, non-cardiovascular treatments, tachycardia management, coronary angioplasty and others.

Based on end-users, it is segmented into academic and research organization, ambulatory centers, hospitals and clinics and others.

Regional Analysis

By region, the drug device combination market insights covers growth opportunities and latest trends across the Americas, Europe, Asia Pacific and Middle East and Africa. Of these, the Americas will sway the market over the assessment period owing to increasing incidence of cardiovascular diseases, presence of key market players, developed healthcare sector in Canada and the US, high healthcare expenditure and suitable reimbursement policies. In the European region, the drug device combination market will have the second major share due to huge patient pool, presence of developed economies, increasing awareness about the device and presence of healthcare infrastructure that is well-developed. In the APAC region, the drug device combination market is expected to grow at the fastest pace owing to growing support from the government for foreign investments, growing healthcare sector and growing penetration of market players here. On the other hand, the drug device combination market in the Middle East and Africa will have minimal share in the market owing to low per capita income and presence of poor economies. The Middle East is anticipated to have a major share in the drug device combination market owing to presence of developed economies such as Dubai, Saudi Arabia, United Arab Emirates and others and increasing funds made by the government in the healthcare sector.

About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street,5Th Floor, New York,

New York 10013

United States of America

Smart Insulin Pens Market Size, Strategies & Key Players Review by Forecast to 2030

 Smart Insulin Pens Market Highlights

The Smart Insulin Pens Market Size was worth USD 0.13 Billion in 2023 and is expected to reach USD 0.26 Billion by 2030 at 11.77% CAGR during the forecast period 2022 - 2030. As per smart insulin pens market analysts, the global market is anticipated to witness growth owing to the factors such as alarming escalation in diabetes cases as well as the escalating pool of diabetics considering surge in obesity. However, the smart insulin pens market will face challenges and restraints due to product recall and the amplified product quality issues during the forecast period 2022 to 2030.

Sedentary lifestyles and aging in the smart insulin pens market is set to play a key role in determining the growth potential during 2022 to 2030 years. Analysts have also studied the smart insulin pens market to understand potential threats and challenges the smart insulin pens market companies could face. Although the smart insulin pens market trends is poised to grow at a fast pace across product type and end-users’ segments, factors such as strict rules and regulations could slow down the smart insulin pens market's growth worldwide.

Competitive Landscape

Smart insulin pens have seen increased demand over the years, due to the commonness of unhealthy eating habits and lifestyles and the collective surge noted in product approvals. Companies functioning in the global smart insulin pens market are also being challenged due to stringent rules and concerns regarding the approval process. Mergers and acquisitions by smart insulin pens market companies are anticipated to help the market during the forecast period 2018 to 2023. As the smart insulin pens market is set to register a high CAGR of 6.92% and is also anticipated to reach a US$23,624.01 million by 2025, the report highlights key areas companies need to focus on. The report suggests that the smart insulin pens market will see a healthy growth in the long run till 2023. Based on SWOT analysis and smart insulin pens market’s analysis based on Porters’ Five Force Model presented in the smart insulin pens market report. Mergers and acquisitions by smart insulin pens market companies are anticipated to help the market during the forecast period 2018 to 2023. 

MRFR recognizes the Global Smart Insulin Pens Market Players are Companion Medical, Eli Lily and Company, Diamesco Co., Ltd., Ypsomed Holding AG, Emperra GmbH E-Health Technologies, Digital Medics Pty Ltd., and Novo Nordisk A/S and Others.

Market Segmentation

The market for smart insulin pens market insights has been segmented into product type and end-users. Based on the segment, which is product type, the market is categorized based on smart pen and connecting device. The global market for smart insulin pens is further segmented based on end-users into hospital/retail pharmacies and online.

The global market research report covers all the aspects of the smart insulin pens market based on the segmental analysis of these product types and end-users’ segments. Analysts have also studied the global smart insulin pens market's regional markets spread across many continents and countries. The product type and end-users’ segments along with their sub-segments have been analysed and companies functioning in the smart insulin pens market across these segments are profiled and analysed based on input and feedback from smart insulin pens industry-based decision makers as well as primary and secondary sources. The smart insulin pens market research report presents analysis-based information for companies functioning in the smart insulin pens market.

Regional Overview

New government rulings or hospital strategies in the wake of the pandemic may hinder the smart insulin pens market growth. The market research report suggests that companies in the smart insulin pens industry could be supported by broadening insurance coverage as well as the massive population suffering from diabetes during the forecast period. The smart insulin pens market is set to register growth at a high CAGR owing to these key factors. The market for smart insulin pens is spread across North America, Europe, Asia-Pacific, and other parts of the world. The global smart insulin pens market research report reveals that APAC, North America, and Europe regional smart insulin pens markets will dominate the global market for smart insulin pens during the forecast period 2018 to 2023. As per smart insulin pens market analysts, the market is set to witness tremendous growth across devices as well as hospitals and clinics segments in North America which covers smart insulin pens markets across the United States, Canada, Mexico, and several other regional markets. Companies active in the smart insulin pens market are also analysed and studied in the smart insulin pens market research report.

The smart insulin pens industry for Europe covers smaller market segments of Germany, Italy, France, and the United Kingdom. Additionally, the smart insulin pens market research report covers the Asia-Pacific region covering smart insulin pens markets from India, China, Japan, Australia, and others. The smart insulin pens market is also spread across the rest of the world. The smart insulin pens market report covers all such regions including the Middle East, Africa, Brazil, and others.

Industry News

Medtronic, a world pioneer in medical devices, revealed today that it will acquire privately owned Companion Medical, the maker of InPen, the only FDA-approved smart insulin pen device with an embedded diabetes care app on the marketplace. The inclusion of Companion Medical's InPen to Medtronic's portfolio broadens the company's potential to help patients at every stage in their disease path and provide them with a unique and vast ecosystem of assistance — independent of how insulin is administered. Companion Medical's acquisition draws on strong algorithms that take advantage of the corporation's deep data analytics and Artificial intelligence.

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street, 5Th Floor,

New York, New York 10013

United States of America

+1 628 258 0071

Email: sales@marketresearchfuture.com

Contrast Media Market Outlook, Size, Share & Key Companies by 2030

Market Summery

Market Research Future (MRFR) predicts the Global Contrast Media Market Share is projected to grow USD 4.2 billion at a CAGR 4.01% during the forecast period of 2023 – 2030. Contrast Media is a substance that enhances the visibility of internal organs during radiography.  Medical imaging plays a crucial role in diagnosis of diseases, like GI disorders, cancer diagnosis, and cardiovascular complications.

The World Health Organization (WHO) reported that by 2020, three-quarters of global deaths will be caused due to chronic diseases of which 71-75% of deaths will be due to cardiac related problems. Early detection of such ailments can help provide patients with better treatment.  The increase in prevalence of chronic disease and cancer patients necessitates better diagnostic techniques provoking elevated use of contrast media. This is expected to bolster the contrast media market in the forecast period.

Medical imaging techniques like, computed tomography (CT) and magnetic resonance imaging (MRI), extensively use contrast media for deriving images of internal organs of a body.  The increase in the number of both public and private diagnostic centres availing such sophisticated medical imaging techniques is another factor identified to propel the market expansion. Owing to technical advancements, the burgeoning healthcare industry is expected to largely influence the contrast media market.

For example, in 2017, GE Healthcare received its FDA approval for Visipaque™ (iodixanol) Injection, a imaging agent that can be used in coronary CT angiography.  Ascelia Pharma, in 2018 announced that it will develop manganese-based contrast media products, which would likely be a safer alternative to gadolinium-based contrast media agents. Designing syringeless contrast media injectors to  improve the route of administration of contrast media, for better patient compliance. Such medical advancements are providing a platform for launching innovative products. MRFR forecast that launch of new products can have a positive impact on the global contrast media market growth in the near future.

Segmental Analysis

The segmental study of the Global Contrast Media Market Outlook gives a compendious market overview that highlights key points of the market that benefits our clients to identify growth opportunities of the market. The contrast media market study is segmented into type, procedure, application, and route of application.

Based on the type, the market is segmented into intravenous contrast materials, iodine-based contrast media agents, and others.

Based on the application, the market is segmented into nephrological disorders, oncology, cardiovascular disorders, and others.

Based on the route of administration, the market is segmented into injectable, rectal, and oral.

Key players

Global contrast media market players are as below

AMAG Pharmaceuticals (US)

Bracco Diagnostic Inc. (Italy)

Lantheus Medical Imaging (U.S.)

Covidien (Ireland)

Mallinckrodt Pharmaceuticals (UK)

Targeson (US)

nanoPET Pharma GmbH (Germany)

NanoScan Imaging (US)

Medrad Inc. (US)

Guerbet Group (France)

Subhra Pharma Private Limited (India)

GE Healthcare (US)

CMC Contrast AB (Sweden)

Daiichi (Japan)

Bayer Healthcare Pharmaceuticals (Germany)

Regional Insights

MRFR’s regional analysis of the Contrast Media Market insight gives a holistic approach towards the demographic progress of the market in the forecast years. Based on the region, the contrast media market is segmented into Asia Pacific, North America, Europe, and the Rest-of-the-World (RoW).

North America is expected to dominate the market, holding a significant market share owing to its strong technological infrastructure. Increase in medical tourism, rise in the number of cancer patients and patients suffering from chronic disorders, and market players likely to deliver cost-competitive contrast media products are factors which are predicted to fuel the regional market growth. 

Robust economic improvement, existence of influential market players, and technological advancements in the European region can augment the regional market proliferation.

The contrast media market in the Asia Pacific region, led by the rapidly proliferating healthcare sector and developing economy, has emerged as a promising market, globally. Increasing markets in countries, such as Japan, China, and India, are pushing up the growth in the regional market. Moreover, the APAC Contrast Media Market is driven by the rising population and the spreading awareness towards the functionalities of contrast media.

The rapidly growing healthcare industry and emerging economies like India, Japan, and China in the Asia Pacific region, a huge population, and increase in awareness towards benefits of contrast media are market dynamics expected to drive the regional market growth.

Related reports

https://healthcaresubmission.blogspot.com/2023/09/pharmaceutical-sterility-testing-market.html

https://medium.com/@suzzensten/pharmaceutical-sterility-testing-market-size-trends-growth-and-forecast-by-2032-e7be3ee4a83c

https://www.patreon.com/posts/pharmaceutical-89914746?utm_medium=clipboard_copy&utm_source=copyLink&utm_campaign=postshare_creator&utm_content=join_link

 

About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street,5Th Floor, New York,

New York 10013

United States of America

Smart Pills Market Outlook, Size, Share & Key Companies by 2032

Market summery

Market Research Future (MRFR's) study on the global smart pills market share is projected to grow USD 2.01 billion by 2032 at a CAGR of 15.9% over the forecast period of 2023-2032. MRFR further asserts that the smart pills market is touted to reach USD 1,800 Mn by the end of 2032.

Amidst cut-throat competition, reimbursement issues, and expiry of blockbuster patent drugs, there is immense pressure on the healthcare sector to innovate diagnosis solutions. This has provided fuel for the advancement and commercialization of the smart pill technology which has been there for decades.

Smart pills are aligned with smart pills such as greater flexibility, precise delivery, real-time measurements, and monitoring of GI tract, and controlled operation or performance have acted as factors which can be employed to great advantage in drug development. They have several important applications, especially in diagnosis.

With the surge in the occurrence of chronic diseases, especially gastrointestinal diseases, smart pills are increasingly emerging as an effective method of endoscopy. Lifestyle diseases such as gastroesophageal reflux disease (GERD), obesity, and gastric ulcers are on the rise due to rapid lifestyle changes and unhealthy eating habits. This has induced high demand for on-site diagnosis, and, in turn, drive the market for smart pills. Surging prevalence of colon cancer is a key factor which is motivating the growth of the smart pills market.

Smart pills have been a breakthrough in gastrointestinal tract diagnosis and are set to replace conventional methods of diagnosis such as colonoscopy and endoscopy. Capsule endoscopy has cropped up as an effective method to perform endoscopy which is non-invasive and causes very little discomfort. Increasing consumer preference for minimally invasive medical procedures is likely to induce greater demand within the smart pills market.

Application of smart pills in monitoring pH, temperature, pressure, and drug adherence are further expected to catapult the growth of the market. Considerable research in the field of smart pills purveyed by heavy investments is also favoring the growth of the market. Other factors fostering market growth include conducive reimbursement landscape and increasing geriatric population. On the other hand, the market growth is restricted by factors such as regulatory restrictions and high costs of smart pills.

Segmentation

The global smart pills market has been segmented based on application, target area, disease indication, and end user.

By application, the smart pills market has been segmented into capsule endoscopy, drug delivery, patient monitoring, and others. The capsule endoscopy segment has been further segmented into small bowel capsule endoscopy, controllable capsule endoscopy, colon capsule endoscopy, and others. The patient monitoring segment has been further segmented into capsule pH monitoring and others.

By target area, the smart pills market has been segmented into esophagus, small intestine, large intestine, and stomach.

By disease indication, the smart pills market has been segmented into esophageal diseases, small bowel disases, colon diseases, and others.

By end user, the smart pills market has been segmented into hospitals, diagnostic center, and research institute.

Competitive Landscape

Global smart pills market players are CapsoVision, Inc., Proteus Digital Health, Inc., JINSHAN Science & Technology, MEDTRONIC, Check-Cap, BDD Limited, Olympus Corporation, PENTAX Medical, FUJIFILM Holdings Corporation, MEDISAFE, INTROMEDIC, and RF Co., Ltd. are the notable players in the global smart pills market.

Regional Analysis

By region, the smart pills market outlook has been segmented into the Americas, Asia Pacific (APAC), Europe, and the Middle East & Africa (MEA).

Conducive reimbursement scenario, the surging prevalence of chronic diseases, a nd fast uptake of advanced technology are the factors supporting the growth of the market in the region. The Americas account for the foremost share of the smart pills market.

Europe follows the Americas closely and accounts for the second most significant share of the smart pills market. Robust healthcare infrastructure, the high incidence rate of lifestyle-related diseases such as obesity, gastroesophageal reflux disease (GERD), and gastric ulcers have generated high demand for smart pills in the region. Moreover, European countries invest heavily in healthcare which acts as a plus for the growth of the market.

The APAC market is poised to perform relatively well and emerge as the fastest-growing market for smart pills. Percolation of advanced healthcare technologies in the region coupled with high healthcare expenditure in the developing countries of the region favors the growth of the market. Besides, increase in geriatric population and prevalence of various chronic diseases contribute to the growth of the market.

The minimum share of the smart pills market is held by MEA. Lack of knowledge, low healthcare penetration, and poor economic conditions, especially in the African region is hindering the growth of the market.

About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street,5Th Floor, New York,

New York 10013

United States of America

North America Dental Consumables Market Size is forecasted to grow by 2032

Dental Consumables Market – Overview

The focus towards dental health has increased the demand for dental consumables significantly over the forecast period. Market focused reports related to the healthcare domain among others recently have been made available by Market Research Future which publishes reports on this market. The North America Dental Consumables Market Size is expected to grow at a CAGR of 2.7% in the forecast period 2023-2032

Increased number of dental practitioners who are utilizing dental consumables has risen considerably in the past few years. Advances in dental procedures have positively reinforced the growth trends of the dental consumables market. Increasing numbers of dental professionals around the world are expected to be instrumental in the development of the market in the coming years. Innovations related to the various areas of dentistry are significant in the expansion of the market. Dental consumables are extensively used due to an escalation in demand for minimally invasive cosmetic dental procedures, particularly in aesthetic dentistry.

Detailed Regional Analysis

The regional analysis of the industry for dental consumables globally comprises of regions such as the Middle East and Africa, Europe, North America, Latin America and the Asia Pacific. The Americas region controls the main market portion and will carry on its role in guiding the market for the duration of the given forecast period due to the high acceptance of novel technologies and increased healthcare expenditures within the region. With the demand for dental consumables growing, due to the developments in dental treatments, shifting demographic trends, and a combination of other factors, the market is expanding at a good pace. Since some of the nations with better medical and healthcare facilities such as Brazil, US, and Canada. The European region is the second significant market due to the presence of well-developed economies and a sound healthcare structure. The rising skills of the oral healthcare domain across altered nations such as the Greece, U.K., Spain, and Italy among others have upgraded the possibility for development of the European region for dental consumables.

Intensification of focus on vendors from emerging markets, such as the Asia Pacific region is expected to improve the pace of market expansion. Additionally, growing demand for refining aesthetic appearance and developing awareness about dental consumables is estimated to positively add to the market development. In addition, the rise in the dental tourism for this region is expected to fuel the market expansion during the forecast period.

Competitive Analysis

The accelerating levels of diversification in the industry, have permitted the companies to use many opportunities available in the industry. The companies in this market are acclimatizing to the state of events by employing portfolio upgrades and preserving financial liquidity. The market value has been enhanced by the constant delivery of customer value. The market competitors are creating their blueprints for corporate strategy in a way that can bring about the best results for development in the current scenario, while also alongside enhancing their product’s value. The prospect for development in the industry appears to be promising through the forecast period. The capability to fuel competitive capabilities is one of the chief causes powering their efforts in this period. Moreover, the contenders are handling the competitive environment by driving the market growth factors to their advantage.

North America Dental Consumables Market Players are

Institut Straumann AG

Henry Schein Inc

Patterson Dental Supply Inc.

Dentsply Sirona

Kerr Corporation

Danaher Corporation

GC orthodontics

Planmeca Oy

American Orthodontics

Industry Segments

The north america dental consumables market insight is segmented on the basis of type and region. The type segment of the market comprises of dental prosthetics, dental restorative material, dental implants and dental regenerative material among others. The region-based segmentation of the dental consumable industry consists of geographical areas such as Europe, Latin America, North America, Middle East, Asia Pacific and Africa.

About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street,5Th Floor, New York,

New York 10013

United States of America

Immunofluorescence Assay Market Players, Segmentation & Analysis by Recent Trends

The global immunofluorescence assay market size is growing pervasively. The market growth attributes to the increase in biological studies in R&D for the detection of biomolecules like glycans, proteins, and small biological and non-biological molecules of various diseases. Also, immunofluorescence assays are primarily used for rapid and sensitive diagnostics of various chronic diseases such as cancer, autoimmune diseases, infectious diseases like HIV, neurological disorders such as Alzheimer's and Parkinson's diseases.

With the intervention of the COVID-19, the immunofluorescence assay industry overview is witnessing a massive demand across the globe. This is due to the rising usages of immunofluorescence assays in the development of antibodies that can detect sars-Cov-2 in patient samples. According to Market Research Future (MRFR), the global Immunofluorescence Assay Market is expected to reach USD 2.7 Billion by 2030 at 6.10% CAGR during the forecast period 2022-2030.

Advancements in medical technology, alongside the increasing R&D funding by industry leaders and governments, boost the market growth. Additionally, rising numbers of preclinical research, alongside the rising studies on antibody therapies, advanced drug discoveries, and oncology diseases, accelerate the market growth. Growing collaborations between research institutes and biotechnology companies are expected to drive the growth of the immunofluorescence assay market.

Conversely, the high cost of immunofluorescence assay products such as diagnostic kits is expected to restrict the market growth during the forecast period. Also, factors such as risks of cross contaminations and shortage of skilled labor & weak detection signals are estimated to impede the growth of this market.  Nevertheless, growing advancements in biotechnology & medical science would support the growth of the market, bringing about cost-effective immunofluorescence assay. 

Global Immunofluorescence Assay Market – Competitive Analysis

Highly competitive, the global immunofluorescence assay market appears fragmented due to the presence of several well-established players. To gain a larger competitive advantage, players incorporate strategies such as mergers & acquisitions, collaborations, expansion, and product/technology launch. Top players make huge investments for R&D and clinical trials to develop these assays. Pharmaceutical companies are the largest investors in the immunofluorescence assay market. 

Major Players: 

The global immunofluorescence assay market Players leading include Abcam plc., Thermo Fisher Scientific, BioLegend, Inc., Enzo Life Sciences, Inc., Sino Biological Inc., BioTek Instruments, Inc., Bio-Rad Laboratories, Inc., Zyagen Cell Signaling Technology, Inc., PerkinElmer Inc., Becton Dickinson and Company, Merck, Agilent Technologies, TCS Biosciences Ltd, and Maxvision Biosciences Inc., among others. 

Global Immunofluorescence Assay Market – Segmentation

The report is segmented into five dynamics; 

By Technique: Primary (Direct) Immunofluorescence Assays and Secondary (Indirect) Immunofluorescence Assays (Salt split technique, Antigenic mapping method, Double Staining method), Micro Immunofluorescence.

By Product Type: Antibodies, Kits & Reagents, Instruments, Microscopes, Imaging Analysis Systems, Labeling dyes, Species Product Type, and others.

By Application: Clinical Research, Clinical Diagnostics, Infectious Diseases, Cancer, Cardiovascular Diseases, Autoimmune Diseases, Neurological Diseases, Research & Development, and others.

By End-User: Biotechnology Companies, Hospitals & Research Institutes, Contract Research Organizations, Diagnostic centers, and others.

By Regions:  Americas, Europe, Asia Pacific, and Rest-of-the-World.

Global Immunofluorescence Assay Market – Regional Analysis

North America dominates the global immunofluorescence assay market insights. The largest market share attributes to the high prevalence of chronic diseases and rising R&D investments within this region. Also, the rising adoption of advanced systems for early diagnosis of diseases drives the regional market growth. Moreover, the advancement in the development techniques and increasing use of nanotechnology in the development of immunofluorescence assay fostered the growth of the regional market.

The US, among other North American countries, holds the largest share in the regional market. Besides, the presence of vast numbers of biotechnology & pharmaceutical companies impacts the regional market growth positively. The North American immunofluorescence assay market is estimated to retain its leading position throughout the assessment period.

Europe stands second in the immunofluorescence assay market. The market is driven by the increasing prevalence of myriads of chronic diseases such as cancer and the rapidly growing biotechnology sector in Europe. Moreover, substantial R&D investments by the public and private sectors, alongside the increasing R & D in biotechnology, foster the market growth in the region. The European immunofluorescence assay market is projected to create a substantial revenue pocket over the review period.

The immunofluorescence assay market in the Asia Pacific region is growing rapidly. Factors such as the growing patient pool, high incidence of chronic diseases, developing healthcare infrastructure, and increasing R&D activities in the biotechnology sector influence the market in this region. Also, the presence of major market players in China, India, and Japan drive market growth. Rising government initiatives increase the size of the immunofluorescence assay market in the region.

The region witnesses rising developments of immunofluorescence assay products, while several products are under the pipeline, which is carried out under license agreements. The APAC immunofluorescence assay market is expected to grow at an impressive CAGR during the predicted period.

About US:

Market Research Future (MRFR) enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street,5Th Floor, New York,

New York 10013